MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Clinical trials for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia: daily infusion drug enters human trials
Disease control Recruiting nowThis study tests a new drug called AB8939 in people whose acute myeloid leukemia (AML) has returned or not responded to prior treatments. The main goal is to find a safe dose and see if the drug can shrink or control the cancer. About 78 adults will receive daily infusions, and r…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated May 26, 2026 05:15 UTC
-
New approach aims to stop Graft-Versus-Host disease in young cancer patients
Disease control Recruiting nowThis study tests whether removing a specific type of immune cell (naive T cells) from donated stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body, causing long-term…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New hope for blood cancer patients: experimental drug combo enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug called cirtuvivint, alone or with another drug (ASTX727), in people with certain blood cancers (MDS and AML). The goal is to find a safe dose and see how well it works. About 54 adults whose cancer has returned or not responded to treatment…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for tough leukemias: experimental drug APL-4098 enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called APL-4098, alone or with standard chemotherapy drugs, in about 100 adults with acute myeloid leukemia (AML) or related blood cancers that have come back or not responded to treatment. The main goals are to check safety, find…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated May 18, 2026 12:10 UTC